Clinical Trials Logo

Allergy clinical trials

View clinical trials related to Allergy.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06401408 Not yet recruiting - Allergy Clinical Trials

Effect of Virtual Reality Headsets on Fear Anxiety and Physiological Parameter in Skin Prick Test

Start date: June 20, 2024
Phase:
Study type: Observational

The goal of this clinical trial is determine the effect of virtual reality headsets on pain, anxiety, fear and physiological parameters in children aged 4-7 years who undergoing skin prick test. The main questions it amis to answer are: Virtual reality headsets effect on the pain that during the procedure Virtual reality headsets effect on the anxiety that occurs during the procedure Virtual reality headsets effect on the fear that occurs during the procedure Virtual reality headsets effect on physiological parameters (heart rate, blood pressure, respiratory rate) during the procedure

NCT ID: NCT06330974 Not yet recruiting - Asthma Clinical Trials

Allergy, Asthma, and Atopic Eczema in Finland

FinnATOPY
Start date: October 2024
Phase:
Study type: Observational [Patient Registry]

The summary is available at --> https://www.finnatopy.fi/summary

NCT ID: NCT06167564 Not yet recruiting - Allergy Clinical Trials

Allergy Diagnostic Test Based on Microchip Technology

Start date: January 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to develop a microarray-based diagnostic test system for the determination of allergen specific IgE in human blood serum.

NCT ID: NCT05997784 Not yet recruiting - Allergy Clinical Trials

Study of Indoor Air Pollutants and Their Impact in Childhood Health and Wellbeing

SynAIR-G
Start date: September 1, 2023
Phase:
Study type: Observational

The number and types of indoor air pollutants in schools is rising, however little is known about the impact of their potentially synergistic interactions, upon schoolchildren health. Among children, highly susceptible individuals to air pollution include allergy and asthma sufferers, and a low socioeconomic background, however no specific guidance is available. The Syn-Air-G project will develop a comprehensive and responsive multipollutant monitoring system (in accessible and actionable formats) by constructing and deploying novel but validated and improved sensors of chemical and biological (allergens, microbes) pollutants) and advancing environmentally friendly interventions (including air purifiers). Health: A comprehensive multidisciplinary and exposome approach of health effects of multi-pollution in small children.

NCT ID: NCT05848986 Not yet recruiting - Allergy Clinical Trials

Study if the Presence of Functional FcERI/RII on the Surface of Human Blood Platelet

FERIplaq
Start date: June 1, 2023
Phase:
Study type: Observational

Anaphylactic shock is the most severe expression of immediate hypersensitivity reactions. The mechanisms leading to these reactions are still poorly understood and may involve platelets, especially in the most severe forms. The IgE ( ImmunoglobulineE)-mediated mechanism, involving the FcERI(the high-affinity receptor for the Fc region of immunoglobulin E (IgE) receptor present on the surface of mast cells and basophilic cells, is the most common mechanism. The receptors FcERI and FcERII are also described as being present on the surface of blood platelets, which would imply their activation along with the other cells involved. However, studies showing the presence of the FcERI/RII receptors on blood platelets suffer from many biases. The main objective of the research is to study whether the FcERI/RII receptors are present and functional on the surface of blood platelets from allergic patients.

NCT ID: NCT05113394 Not yet recruiting - Asthma Clinical Trials

Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy

PAPA
Start date: February 1, 2024
Phase: Phase 2
Study type: Interventional

To establish efficacy and safety of HDM sublingual Immunotherapy (HDM-SLIT) by comparing Odactra and placebo, when given sublingually for 3 years to high risk infants aged between 6 to 12 months at enrollment in preventing the development of asthma, assessed 1.5 years after discontinuation of treatment.

NCT ID: NCT04928638 Not yet recruiting - Asthma Clinical Trials

Educational Intervention for Asthmatic and Allergic Patients

Start date: June 12, 2021
Phase: N/A
Study type: Interventional

Despite its importance, there are few studies that implement the use of new technologies in the approach to patients with asthma and allergy. Therefore, the objective of this study is to evaluate the effectiveness of a telematic educational intervention in patients with allergies and / or asthma

NCT ID: NCT04297098 Not yet recruiting - Asthma Clinical Trials

Pain Sensitivity Evaluation in Respiratory Patients

Start date: February 24, 2020
Phase:
Study type: Observational

Previous studies have reported that asthmatic or chronic pulmonary obstructive disease patients have an increased response to pain stimulus. However, this aspect has not been evaluated in allergic patients. Additionally, the difference in pain sensitivity between asymptomatic period crisis have not been evaluated yet.

NCT ID: NCT04071821 Not yet recruiting - Allergy Clinical Trials

Relative Bioavailability Study to Evaluate Cetirizine HCl Gummy 10 mg and Cetirizine HCl Oral Tablets 10 mg

Start date: May 1, 2025
Phase: Phase 1
Study type: Interventional

A Randomized, Open-Label, Single-Dose, Five-Period Crossover, Relative Bioavailability Study to Evaluate Cetirizine HCl Gummy 10 mg and Cetirizine HCl Oral Tablets 10 mg Administered in Healthy Adult Male and Female Subjects

NCT ID: NCT03915197 Not yet recruiting - Asthma Clinical Trials

Acute Bronchiolitis in Infants and Allergic Asthma

Start date: May 2, 2019
Phase: N/A
Study type: Interventional

Predicting the risk of allergenic sensitizations and asthma development in the first year of life is difficult. Investigator decided to follow prospectively two cohorts of infants with acute bronchiolitis, hospitalized or treated at home, from the epidemic seasons of 2011-2012 and 2015-2017 to know their respiratory evolution, especially if they developed allergen sensitization and / or asthma.